ArticleCancer research2020

A Bis-Indole-Derived NR4A1 Antagonist Induces PD-L1 Degradation and Enhances Antitumor Immunity.

Keshav Karki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.